Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company...
-
NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
NurExone released a corporate update and reported financial results for the quarter ended September 30, 2023.